|
METT5D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62569957495862E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23290266884624E-12 |
| Normal-vs-Stage2 |
7.00140001530514E-09 |
| Normal-vs-Stage3 |
7.58171303516519E-13 |
| Normal-vs-Stage4 |
1.66533453693773E-12 |
| Stage1-vs-Stage2 |
5.268200E-01 |
| Stage1-vs-Stage3 |
2.359600E-02 |
| Stage1-vs-Stage4 |
1.240800E-03 |
| Stage2-vs-Stage3 |
3.425000E-01 |
| Stage2-vs-Stage4 |
3.162000E-02 |
| Stage3-vs-Stage4 |
2.084800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
4.5939999999689E-06 |
| Normal-vs-Asian |
4.24610002713877E-09 |
| Caucasian-vs-AfricanAmerican |
8.843200E-01 |
| Caucasian-vs-Asian |
5.779800E-01 |
| AfricanAmerican-vs-Asian |
6.655600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.56426041195846E-13 |
| Normal-vs-Female |
1.63791202822949E-12 |
| Male-vs-Female |
5.616800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38949962646961E-11 |
| Normal-vs-Age(41-60Yrs) |
1.2516654379624E-12 |
| Normal-vs-Age(61-80Yrs) |
2.01383354436757E-12 |
| Normal-vs-Age(81-100Yrs) |
2.2978999999923E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.692600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.857700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.241840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.302200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.891000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.315400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.231900E-02 |
| Classical-VS-Follicular |
5.599800E-01 |
| Classical-VS-Other |
5.343800E-01 |
| Classical-VS-Normal |
1.72162284428623E-12 |
| Tall-VS-Follicular |
3.253900E-02 |
| Tall-VS-Other |
1.249370E-01 |
| Tall-VS-Normal |
9.89259785200147E-11 |
| Follicular-VS-Other |
7.018200E-01 |
| Follicular-VS-Normal |
2.09770000259013E-08 |
| Other-VS-Normal |
3.045900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.66324764861292E-13 |
| Normal-vs-N1 |
2.57169840978122E-11 |
| N0-vs-N1 |
1.919770E-01 |
|
|
